Brady Martz Wealth Solutions LLC acquired a new stake in shares of The Procter & Gamble Company (NYSE:PG - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,087 shares of the company's stock, valued at approximately $972,000.
Several other institutional investors have also modified their holdings of the stock. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble in the second quarter valued at approximately $28,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of Procter & Gamble in the 3rd quarter worth $33,000. Costello Asset Management INC grew its position in shares of Procter & Gamble by 2,142.9% during the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company's stock worth $54,000 after buying an additional 300 shares in the last quarter. William B. Walkup & Associates Inc. bought a new stake in shares of Procter & Gamble in the second quarter valued at about $58,000. Finally, Mendota Financial Group LLC lifted its position in shares of Procter & Gamble by 58.0% in the 4th quarter. Mendota Financial Group LLC now owns 376 shares of the company's stock worth $63,000 after purchasing an additional 138 shares during the period. 65.77% of the stock is owned by institutional investors.
Insider Buying and Selling
In other news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares of the company's stock, valued at $7,189,463.68. This represents a 54.48 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the business's stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the sale, the insider now directly owns 11,595 shares in the company, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 73,447 shares of company stock valued at $12,978,820. 0.18% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on the company. Piper Sandler assumed coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a "neutral" rating and a $174.00 price target for the company. Hsbc Global Res raised shares of Procter & Gamble to a "strong-buy" rating in a research report on Friday, October 4th. DA Davidson reaffirmed a "buy" rating and issued a $209.00 price target on shares of Procter & Gamble in a report on Friday, December 27th. Barclays lowered their price objective on Procter & Gamble from $163.00 to $155.00 and set an "equal weight" rating for the company in a research report on Friday. Finally, Morgan Stanley increased their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a research note on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and a consensus target price of $179.65.
Get Our Latest Report on Procter & Gamble
Procter & Gamble Stock Performance
PG traded up $0.64 on Tuesday, reaching $161.77. The stock had a trading volume of 13,904,402 shares, compared to its average volume of 7,422,382. The business's 50-day moving average price is $169.09 and its two-hundred day moving average price is $169.44. The company has a market cap of $380.96 billion, a P/E ratio of 27.89, a price-to-earnings-growth ratio of 3.63 and a beta of 0.45. The Procter & Gamble Company has a 12-month low of $146.28 and a 12-month high of $180.43. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion during the quarter, compared to analysts' expectations of $21.99 billion. During the same quarter in the prior year, the firm posted $1.83 EPS. Procter & Gamble's quarterly revenue was down .6% compared to the same quarter last year. Sell-side analysts forecast that The Procter & Gamble Company will post 6.92 earnings per share for the current year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.49%. Procter & Gamble's dividend payout ratio (DPR) is 69.48%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.